The show that explains the why behind the headlines. This edition explores how Ireland became a global pharmaceutical powerhouse - and the risks of becoming too dependent on a handful of multinational companies. It also examines why India's wealth is shifting from traditional assets such as gold and property into startups, as a new generation of investors reshapes the country's capital landscape.






